Literature DB >> 15592812

Recombinant FVII in orthotopic liver transplantation (OLT): a preliminary single centre experience.

Andrea De Gasperi, Francesco Baudo, Luciano De Carlis.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15592812     DOI： 10.1007/s00134-004-2525-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Coagulopathies in hepatic disease.

Authors:  Y Kang
Journal:  Liver Transpl       Date:  2000-07       Impact factor: 5.799

Review 2.  Recombinant FVIIa for intractable hemorrhage: more questions than answers.

Authors:  Nigel S Key
Journal:  Transfusion       Date:  2003-12       Impact factor: 3.157

3.  Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.

Authors:  H G Hendriks; K Meijer; J T de Wolf; I J Klompmaker; R J Porte; P J de Kam; A J Hagenaars; T Melsen; M J Slooff; J van der Meer
Journal:  Transplantation       Date:  2001-02-15       Impact factor: 4.939

4.  Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.

Authors:  R J Porte; I Q Molenaar; B Begliomini; T H Groenland; A Januszkiewicz; L Lindgren; G Palareti; J Hermans; O T Terpstra
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

5.  Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.

Authors:  Ichiro Yasuda; Yoshimune Shiratori; Seiji Adachi; Akihiro Obora; Masao Takemura; Masataka Okuno; Yoshihiro Shidoji; Mitsuru Seishima; Yasutoshi Muto; Hisataka Moriwaki
Journal:  J Hepatol       Date:  2002-05       Impact factor: 25.083
  5 in total
  1 in total

Review 1.  Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.

Authors:  Veronica Yank; C Vaughan Tuohy; Aaron C Logan; Dena M Bravata; Kristan Staudenmayer; Robin Eisenhut; Vandana Sundaram; Donal McMahon; Ingram Olkin; Kathryn M McDonald; Douglas K Owens; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.